The U.N. health agency said late Saturday that it has so far received reports of at least 169 cases of "acute hepatitis of unknown origin'' from a dozen countries.
The new regulations, which govern the Patented Medicine Prices Review Board, will lower pharmaceutical industry profits by $2.9 billion over a decade, rather than the $8.8 billion anticipated previously.
